Eisai Co. Ltd.

TKS: JP:4523

GO
/marketstate/country/jp

Market closed

/zigman2/quotes/203064480/delayed

¥

8,777.00

Change

+222.00 +2.59%

Volume

Volume 2.51m

Sep 28, 2021, 3:00 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/203064480/delayed

Previous close

¥ 8,555.00

¥ 8,777.00

Change

+222.00 +2.59%

Day low

Day high

¥8,581

¥8,926

Open
Open: 8,600.00

52 week low

52 week high

¥6,705

¥12,765

Open

Market cap

¥2478.87B

Average volume

1.45M

P/E ratio

42.04

Rev. per Employee

¥57.48M

EPS

208.76

Dividend

80.00

Div yield

1.82%

Ex dividend date

9/29/21

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/jp/4523

MarketWatch News on 4523

  1. Eisai to pull weight-loss drug due to cancer concerns

    9:43 a.m. Feb. 14, 2020

    - Jaimy Lee

  2. Biogen says it will pursue FDA approval of early Alzheimer's drug

    6:39 a.m. Oct. 22, 2019

    - Steve Goldstein

  3. Biogen, Eisai to discontinue phase 3 trial of oral BACE Alzheimer's treatment

    8:05 a.m. Sept. 13, 2019

    - Tomi Kilgore

  4. Biogen says trial to be halted because it was unlikely to meet primary goal

    7:02 a.m. March 21, 2019

    - Ciara Linnane

  5. Biogen and Eisai to discontinue phase 3 trial of Alzheimer's treatment

    7:01 a.m. March 21, 2019

    - Ciara Linnane

  6. Loading more headlines...
/news/nonmarketwatch/company/jp/4523

Other News on 4523

  1. Alzheimer’s Setback Is Warning to Biogen Investors

    7:44 p.m. Dec. 21, 2017

    - The Wall Street Journal Interactive Edition

  2. Eisai Expects Strong Sales From New Cancer Drug

    6:05 a.m. Feb. 12, 2015

    - The Wall Street Journal Interactive Edition

  3. FDA Approves Weight-Loss Drug

    12:51 p.m. Sept. 11, 2014

    - The Wall Street Journal Interactive Edition

  4. More Consolidation in Cancer Space Expected

    2:18 p.m. April 23, 2014

    - The Wall Street Journal Interactive Edition

  5. Forest Labs to Cut 500 Jobs in Restructuring

    11:17 p.m. Dec. 2, 2013

    - The Wall Street Journal Interactive Edition

  6. DEA Moves Toward Permitting Sales of Epilepsy Pill

    4:21 p.m. Oct. 25, 2013

    - The Wall Street Journal Interactive Edition

  7. Japan's Eisai Sues DEA, Seeking Clearance of Epilepsy Drug

    10:33 p.m. Aug. 19, 2013

    - The Wall Street Journal Interactive Edition

  8. Alzheimer's Families Clamor for Drug

    11:53 a.m. Feb. 13, 2012

    - The Wall Street Journal Interactive Edition

  9. New Attack on Alzheimer's

    11:59 p.m. Feb. 9, 2012

    - The Wall Street Journal Interactive Edition

  10. Dr. Reddy Profit Rises 25%, Misses Forecast

    9:42 a.m. July 20, 2011

    - The Wall Street Journal Interactive Edition

  11. Takeda Bid May Fuel M&A Wave

    6:49 a.m. May 16, 2011

    - The Wall Street Journal Interactive Edition

  12. Takeda's Bid for Nycomed May Herald M&A Wave

    9:10 a.m. May 15, 2011

    - The Wall Street Journal Interactive Edition

  13. Amylin, Takeda Halt Obesity Drug Study

    1:04 p.m. March 16, 2011

    - The Wall Street Journal Interactive Edition

  14. Ranbaxy Profit Soars

    2:01 p.m. Feb. 22, 2011

    - The Wall Street Journal Interactive Edition

  15. New Concerns About Arena Pharma's Diet Drug

    1:14 p.m. Jan. 28, 2011

    - The Wall Street Journal Interactive Edition

  16. FDA Seeks Data on Vivus Obesity Drug

    5:34 p.m. Jan. 21, 2011

    - The Wall Street Journal Interactive Edition

  17. Arena to Resubmit Diet- Drug Application

    11:36 a.m. Dec. 22, 2010

    - The Wall Street Journal Interactive Edition

  18. Elan, Eisai to Pay $214 Million to U.S.

    8:30 p.m. Dec. 15, 2010

    - The Wall Street Journal Interactive Edition

  19. Otsuka Rises 1.9% in Tokyo Debut

    12:57 p.m. Dec. 15, 2010

    - The Wall Street Journal Interactive Edition

  20. Loading more headlines...
/news/pressrelease/company/jp/4523

Press Releases on 4523

No News currently available for 4523

Rates »

Trending Tickers
  • /zigman2/quotes/207505872/composite DISH+1.05%
  • /zigman2/quotes/204151124/composite CURE-1.23%
  • /zigman2/quotes/214908404/composite GFL+1.15%
  • /zigman2/quotes/204236046/composite DUST+1.32%
  • /zigman2/quotes/200683073/composite FRC+0.90%
X
Powered by StockTwits
Link to MarketWatch's Slice.